SlideShare une entreprise Scribd logo
1  sur  40
Adrenergic Drugs II Aims To understand the actions and side effects of major adrenergic drugs, and their clinical applications Read:  Chapter 8, Rang and Dale comments to Dr Ian Musgrave (336S) Email:  Ian.Musgrave@adelaide.edu.au
Sympathomimetics: Types ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Amphetamine - indirect agonist ,[object Object],[object Object],[object Object],[object Object]
Amphetamine - indirect agonist
Ephedrine ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Tyramine ,[object Object],[object Object],[object Object],[object Object]
Cocaine ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Close up of Adrenergic terminal NA NA NA NA Tyrosine Dopamine DOPA NA MAO NA NA Metabolites Uptake 1 Vesicular transporter TH DDC D  H Vesicular  transporter Cocaine
Sympathomimetic Uses ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Sympatholytics: Types ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Directly acting sympatholytics - antagonists ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Adrenergic antagonists ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Non-selective alpha antagonists ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Non-selective alpha antagonists - structure Phentolamine Tolazoline Phenoxybenzamine Active intermediate (ethyleneimonium)
Effect of tolazoline and phenoxybenzamine on noradrenergic contraction in cat splenic strips + Tolazoline + Phenoxybenzamine Competitive vs non-competitive antagonism
Problems with non-selective alpha antagonists  ,[object Object],[object Object],[object Object],[object Object],[object Object]
Selective alpha antagonists Prazosin ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Adrenaline “reversal” adrenaline adrenaline Prazosin Blood Presure Blockade of vasoconstrictor   1 -adrenoceptors reveals vasodilator   -adrenoceptors Time Time Blood pressure recordings in anaesthetised dog
Alpha antagonists: Uses ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Beta antagonists: Types ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Beta antagonists - structure Propranolol (non-selective) Atenolol (  1 -selective) ICI 118551 (  2 -selective) Pindolol (intrinsic activity)
Effect of a beta-antagonist on heart rate
Non-selective   -antagonist Propranolol ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Adrenaline with and without propranolol adrenaline adrenaline propranolol Blodd Pressure Blockade of vasodilator   -adrenoceptors reveals vasoconstrictor   -adrenoceptors  Time Time
Propranolol Bioavailability Peripheral  Circulation propranolol Intestine Portal vein liver 100 % 30 % metabolites 70 %
Selective    -antagonist Atenolol ,[object Object],[object Object],[object Object],[object Object],[object Object]
Effects of Beta Blockade ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Relative Contraindications ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Antagonists with Intrinsic Sympathomimetic Activity Pindolol ,[object Object],[object Object],[object Object],[object Object],[object Object]
Clinical uses of   -antagonists ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Clinical uses of   -antagonists (cont) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Agonist structure-activity relationships ,[object Object],[object Object],[object Object],[object Object]
Cartoon of adrenergic receptors  showing the 7 transmembrane spanning domains G S Family G i/o Family Adenylyl cyclase +ve -ve ATP cAMP  -adrenoceptors  2 -adrenoceptors Biological response cAMP dependent protein kinase
Structure-activity relationships Looking down on the   -adrenoceptor from outside the membrane  with adrenaline in the binding site between transmembrane domains 3,5 and 6 (model based on rhodopsin crystal structure) TM3 TM5 TM6
Structure-activity relationships  close up of binding site with adrenaline TM6 TM6 TM3
Agonist structure-activity relationships
Antagonist structure-activity relationships
Indirect sympatholytics NA NA NA MeNA Tyrosine Dopamine DOPA NA NA NA Uptake 1 Vesicular transporter TH DDC D  H Reserpine -ve Guanethidine -ve MethylDOPA  -Methyl tyrosine -ve
Indirect sympatholytics: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Indirect sympatholytics: ,[object Object],[object Object],[object Object],[object Object]

Contenu connexe

Tendances

Tendances (20)

Adrenergic neurotransmission
Adrenergic neurotransmissionAdrenergic neurotransmission
Adrenergic neurotransmission
 
Sympathomimetic Drugs
Sympathomimetic Drugs Sympathomimetic Drugs
Sympathomimetic Drugs
 
Sympatholytics
SympatholyticsSympatholytics
Sympatholytics
 
Drugs that act on CNS
Drugs that act on CNSDrugs that act on CNS
Drugs that act on CNS
 
Adrenergic receptors and its modulators
Adrenergic receptors and its modulatorsAdrenergic receptors and its modulators
Adrenergic receptors and its modulators
 
Adrenergic Antagonists
Adrenergic AntagonistsAdrenergic Antagonists
Adrenergic Antagonists
 
Sympathomimetic
SympathomimeticSympathomimetic
Sympathomimetic
 
Adrenergic drugs - pharmacology
Adrenergic drugs - pharmacology Adrenergic drugs - pharmacology
Adrenergic drugs - pharmacology
 
drugs acting on autonomic nervous system
drugs acting on autonomic nervous systemdrugs acting on autonomic nervous system
drugs acting on autonomic nervous system
 
Adrenergic system
Adrenergic systemAdrenergic system
Adrenergic system
 
UNIT II: DRUGS ACTING ON AUTONOMIC NERVOUS SYSTEM
UNIT II: DRUGS ACTING ON AUTONOMIC NERVOUS SYSTEMUNIT II: DRUGS ACTING ON AUTONOMIC NERVOUS SYSTEM
UNIT II: DRUGS ACTING ON AUTONOMIC NERVOUS SYSTEM
 
parasympathomimetics drugs
  parasympathomimetics drugs  parasympathomimetics drugs
parasympathomimetics drugs
 
pharmacology of general anesthetics
pharmacology of general anestheticspharmacology of general anesthetics
pharmacology of general anesthetics
 
Narcotics and non narcotics analgesics
Narcotics and non narcotics analgesicsNarcotics and non narcotics analgesics
Narcotics and non narcotics analgesics
 
Sympathomimetics
SympathomimeticsSympathomimetics
Sympathomimetics
 
Parasympathomimetics and parasympatholytics Pharmacology.
Parasympathomimetics and parasympatholytics Pharmacology. Parasympathomimetics and parasympatholytics Pharmacology.
Parasympathomimetics and parasympatholytics Pharmacology.
 
Ganglionic stimulants and blockers suffi
Ganglionic stimulants and blockers suffiGanglionic stimulants and blockers suffi
Ganglionic stimulants and blockers suffi
 
Unit 3 Drugs Affecting PNS (As per PCI syllabus)
Unit 3 Drugs Affecting PNS (As per PCI syllabus)Unit 3 Drugs Affecting PNS (As per PCI syllabus)
Unit 3 Drugs Affecting PNS (As per PCI syllabus)
 
Sympatholytics.pptx
Sympatholytics.pptxSympatholytics.pptx
Sympatholytics.pptx
 
Antihypertensive drug
Antihypertensive drugAntihypertensive drug
Antihypertensive drug
 

Similaire à Adrenergic Drugs II

Cholinergic antagonists
Cholinergic antagonistsCholinergic antagonists
Cholinergic antagonists
coolboy101pk
 
Adrenergic blockers
Adrenergic blockersAdrenergic blockers
Adrenergic blockers
raj kumar
 
Sympatholytics or Adrenergic Antagonists
Sympatholytics or Adrenergic AntagonistsSympatholytics or Adrenergic Antagonists
Sympatholytics or Adrenergic Antagonists
Ahmad Naeem
 
Atenolol Presentation Clin 210 50
Atenolol   Presentation Clin 210 50Atenolol   Presentation Clin 210 50
Atenolol Presentation Clin 210 50
Dr.RAJEEV KASHYAP
 

Similaire à Adrenergic Drugs II (20)

Antiadrenergic Drugs
Antiadrenergic DrugsAntiadrenergic Drugs
Antiadrenergic Drugs
 
Adrenergic drugs and there classification
Adrenergic drugs and there  classificationAdrenergic drugs and there  classification
Adrenergic drugs and there classification
 
Respiratory drugs.pptx
Respiratory drugs.pptxRespiratory drugs.pptx
Respiratory drugs.pptx
 
Adrenergic bockers (VK)
Adrenergic bockers (VK)Adrenergic bockers (VK)
Adrenergic bockers (VK)
 
Sympatholytics by kahkesha
Sympatholytics   by kahkeshaSympatholytics   by kahkesha
Sympatholytics by kahkesha
 
Antiadrenergic drugs - drdhriti
Antiadrenergic drugs - drdhritiAntiadrenergic drugs - drdhriti
Antiadrenergic drugs - drdhriti
 
Antidrenergic Drugs (updated 2016) - drdhriti
Antidrenergic Drugs (updated 2016) - drdhritiAntidrenergic Drugs (updated 2016) - drdhriti
Antidrenergic Drugs (updated 2016) - drdhriti
 
Adrenergic_agonist_antagonist
Adrenergic_agonist_antagonistAdrenergic_agonist_antagonist
Adrenergic_agonist_antagonist
 
Adrenergic and cholinergic agents
Adrenergic and cholinergic agents Adrenergic and cholinergic agents
Adrenergic and cholinergic agents
 
Sympatholytics
SympatholyticsSympatholytics
Sympatholytics
 
Adrenergic drugs 2020
Adrenergic drugs 2020Adrenergic drugs 2020
Adrenergic drugs 2020
 
16633431.ppt
16633431.ppt16633431.ppt
16633431.ppt
 
Anti hypertensive Drugs
Anti hypertensive DrugsAnti hypertensive Drugs
Anti hypertensive Drugs
 
Cholinergic antagonists
Cholinergic antagonistsCholinergic antagonists
Cholinergic antagonists
 
Adrenergic blockers
Adrenergic blockersAdrenergic blockers
Adrenergic blockers
 
antiparkinson drug-Dopamine precursors,levodopa,cabidopa,bromocriptyne,rponir...
antiparkinson drug-Dopamine precursors,levodopa,cabidopa,bromocriptyne,rponir...antiparkinson drug-Dopamine precursors,levodopa,cabidopa,bromocriptyne,rponir...
antiparkinson drug-Dopamine precursors,levodopa,cabidopa,bromocriptyne,rponir...
 
Atropine
Atropine Atropine
Atropine
 
Sympatholytics or Adrenergic Antagonists
Sympatholytics or Adrenergic AntagonistsSympatholytics or Adrenergic Antagonists
Sympatholytics or Adrenergic Antagonists
 
Atenolol Presentation Clin 210 50
Atenolol   Presentation Clin 210 50Atenolol   Presentation Clin 210 50
Atenolol Presentation Clin 210 50
 
drugs that affect the autonomic nervous system.ppt [autosaved] [autosaved]
drugs that affect the autonomic nervous system.ppt [autosaved] [autosaved]drugs that affect the autonomic nervous system.ppt [autosaved] [autosaved]
drugs that affect the autonomic nervous system.ppt [autosaved] [autosaved]
 

Plus de coolboy101pk (20)

4 -reproductive_system
4  -reproductive_system4  -reproductive_system
4 -reproductive_system
 
Reproductive embryology
Reproductive embryologyReproductive embryology
Reproductive embryology
 
Renalsystem
RenalsystemRenalsystem
Renalsystem
 
Nasal cavity
Nasal cavityNasal cavity
Nasal cavity
 
Legg calve perthes disease donnely 2001 5afad2fc5e0b007027c03a29b821eb3c
Legg calve perthes disease donnely 2001 5afad2fc5e0b007027c03a29b821eb3cLegg calve perthes disease donnely 2001 5afad2fc5e0b007027c03a29b821eb3c
Legg calve perthes disease donnely 2001 5afad2fc5e0b007027c03a29b821eb3c
 
Intestinal obstruction
Intestinal  obstructionIntestinal  obstruction
Intestinal obstruction
 
Diagnosis tx-planning
Diagnosis tx-planningDiagnosis tx-planning
Diagnosis tx-planning
 
Meckels div
Meckels divMeckels div
Meckels div
 
Meckelsdiverticulum
MeckelsdiverticulumMeckelsdiverticulum
Meckelsdiverticulum
 
Surgery cholangitis[1]
Surgery cholangitis[1]Surgery cholangitis[1]
Surgery cholangitis[1]
 
Lung Abscess
Lung AbscessLung Abscess
Lung Abscess
 
Lung abscess
Lung abscessLung abscess
Lung abscess
 
Descriptive and Analytical Epidemiology
Descriptive and Analytical Epidemiology Descriptive and Analytical Epidemiology
Descriptive and Analytical Epidemiology
 
ecg
ecgecg
ecg
 
Ecg 4
Ecg 4Ecg 4
Ecg 4
 
Ecg 7
Ecg 7Ecg 7
Ecg 7
 
Ecg 1
Ecg 1Ecg 1
Ecg 1
 
Ecg 3
Ecg 3Ecg 3
Ecg 3
 
Ecg 5
Ecg 5Ecg 5
Ecg 5
 
Ecg 6
Ecg 6Ecg 6
Ecg 6
 

Adrenergic Drugs II

  • 1. Adrenergic Drugs II Aims To understand the actions and side effects of major adrenergic drugs, and their clinical applications Read: Chapter 8, Rang and Dale comments to Dr Ian Musgrave (336S) Email: Ian.Musgrave@adelaide.edu.au
  • 2.
  • 3.
  • 5.
  • 6.
  • 7.
  • 8. Close up of Adrenergic terminal NA NA NA NA Tyrosine Dopamine DOPA NA MAO NA NA Metabolites Uptake 1 Vesicular transporter TH DDC D  H Vesicular transporter Cocaine
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14. Non-selective alpha antagonists - structure Phentolamine Tolazoline Phenoxybenzamine Active intermediate (ethyleneimonium)
  • 15. Effect of tolazoline and phenoxybenzamine on noradrenergic contraction in cat splenic strips + Tolazoline + Phenoxybenzamine Competitive vs non-competitive antagonism
  • 16.
  • 17.
  • 18. Adrenaline “reversal” adrenaline adrenaline Prazosin Blood Presure Blockade of vasoconstrictor  1 -adrenoceptors reveals vasodilator  -adrenoceptors Time Time Blood pressure recordings in anaesthetised dog
  • 19.
  • 20.
  • 21. Beta antagonists - structure Propranolol (non-selective) Atenolol (  1 -selective) ICI 118551 (  2 -selective) Pindolol (intrinsic activity)
  • 22. Effect of a beta-antagonist on heart rate
  • 23.
  • 24. Adrenaline with and without propranolol adrenaline adrenaline propranolol Blodd Pressure Blockade of vasodilator  -adrenoceptors reveals vasoconstrictor  -adrenoceptors Time Time
  • 25. Propranolol Bioavailability Peripheral Circulation propranolol Intestine Portal vein liver 100 % 30 % metabolites 70 %
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.
  • 32.
  • 33. Cartoon of adrenergic receptors showing the 7 transmembrane spanning domains G S Family G i/o Family Adenylyl cyclase +ve -ve ATP cAMP  -adrenoceptors  2 -adrenoceptors Biological response cAMP dependent protein kinase
  • 34. Structure-activity relationships Looking down on the  -adrenoceptor from outside the membrane with adrenaline in the binding site between transmembrane domains 3,5 and 6 (model based on rhodopsin crystal structure) TM3 TM5 TM6
  • 35. Structure-activity relationships close up of binding site with adrenaline TM6 TM6 TM3
  • 38. Indirect sympatholytics NA NA NA MeNA Tyrosine Dopamine DOPA NA NA NA Uptake 1 Vesicular transporter TH DDC D  H Reserpine -ve Guanethidine -ve MethylDOPA  -Methyl tyrosine -ve
  • 39.
  • 40.